NEPH Nephros
- 2.320
- +0.090+4.04%
- 2.260
- -0.060-2.59%
Nephros News
Nephros Inc to Present Corporate Strategies at Showcase
Nephros to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Nephros(NEPH.US) Director Buys US$17,129.7 in Common Stocks
$Nephros(NEPH.US)$ Director Amron Arthur H purchased 7,000 shares of Common Stocks on Mar 12, 2024 at an average price of $2.4471 for a total value of $17,129.7.Source: Announcement What is statement
Nephros Director Arthur Amron Buys $17.1k in Company Stock
US$4.75 - That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After These Results
As you might know, Nephros, Inc. (NASDAQ:NEPH) last week released its latest full-year, and things did not turn out so great for shareholders. Revenues missed expectations somewhat, coming in at
Nephros Poised for Growth: A Buy Recommendation Amid Expansion and Optimized Operations
Nephros Price Target Announced at $5.00/Share by Benchmark
Nephros Price Target Announced at $5.00/Share by Benchmark
Nephros Raised to Speculative Buy From Hold by Benchmark
Nephros Raised to Speculative Buy From Hold by Benchmark
Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target
Benchmark analyst Robert Wasserman upgrades Nephros from Hold to Speculative Buy and announces $5 price target.
Nephros Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/08/2024 70.65% Benchmark → $5 Upgrades Hold → Speculative Buy 01/26/2021 326.62% B. Riley Securities →
Nephros, Inc. (NASDAQ:NEPH) Q4 2023 Earnings Call Transcript
Nephros Poised for Growth: Strong Financials and Strategic Initiatives Secure Buy Rating
Earnings Call Summary | Nephros(NEPH.US) Q4 2023 Earnings Conference
The following is a summary of the Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript:Financial Performance:Nephros reported a 27% year-over-year increase in Q4 revenue taking it to $3.3 million, an
Nephros: Q4 Earnings Insights
Nephros (NASDAQ:NEPH) reported its Q4 earnings results on Thursday, March 7, 2024 at 04:15 PM.Here's what investors need to know about the announcement.EarningsNephros missed estimated earnings by -20
Express News | Nephros Q4 2023 GAAP EPS $(0.060) Misses $(0.030) Estimate, Sales $3.300M Miss $3.813M Estimate
Press Release: Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. • Stevanato Gr (NYSE:STVN) is likely to report quarte
Earnings Outlook For Nephros
Nephros (NASDAQ:NEPH) is set to give its latest quarterly earnings report on Thursday, 2024-03-07. Here's what investors need to know before the announcement.Analysts estimate that Nephros will report
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today
11 Consumer Discretionary Stocks Moving In Monday's Intraday Session
GainersInteractive Strength (NASDAQ:TRNR) stock moved upwards by 41.0% to $0.9 during Monday's regular session. The market value of their outstanding shares is at $12.9 million. Sleep Number (NASDAQ:S
Analysis
Price Target
No Data
